Zinc sulfate
- Generic Name
- Zinc sulfate
- Brand Names
- Anodan-HC, Anusol, Egozinc, Multitrace-4, Multitrace-5, Proctodan-HC, Rectogel, Riva-sol HC, Tandem Plus
- Drug Type
- Small Molecule
- Chemical Formula
- O4SZn
- CAS Number
- 7733-02-0
- Unique Ingredient Identifier
- 0J6Z13X3WO
- Background
Zinc sulfate is the inorganic compound with the formula ZnSO4 and historically known as "white vitriol". It is on the World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system.
- Indication
This medication is a mineral used to treat or prevent low levels of zinc alone and together with oral rehydration therapy (ORT). It is also used as a topical astringent. Zinc Sulfate Injection, USP is indicated for use as a supplement to intravenous solutions given for TPN.
- Associated Conditions
- Dry Eyes, Local itching, Localized pain, Localized swelling
- Associated Therapies
- Nutritional supplementation
Oral Zinc for the Treatment of Acute Diarrhea in US Children
- Conditions
- DiarrheaGastroenteritis
- Interventions
- Drug: Placebo oral capsule
- First Posted Date
- 2010-09-10
- Last Posted Date
- 2018-08-22
- Lead Sponsor
- Boston Children's Hospital
- Target Recruit Count
- 71
- Registration Number
- NCT01198587
- Locations
- 🇺🇸
Children's Hospital Boston, Boston, Massachusetts, United States
Efficacy of Zinc Sulfate With Probiotics for the Treatment of Acute Diarrhea in Children
- First Posted Date
- 2010-06-09
- Last Posted Date
- 2010-06-10
- Lead Sponsor
- University Hospital No 1 Wroclaw
- Target Recruit Count
- 256
- Registration Number
- NCT01140074
- Locations
- 🇵🇱
Klinika Pediatrii i Chorob Infekcyjnych Akademii Medycznej we Wroclawiu, Wroclaw, Poland
🇵🇱Szpital im Sw Jadwigi w Trzebicy, Trzebnica, Poland
Safety and Dose Escalation Study of Zinc Supplementation in Critically Ill Children
- First Posted Date
- 2010-02-04
- Last Posted Date
- 2019-08-20
- Lead Sponsor
- UCSF Benioff Children's Hospital Oakland
- Target Recruit Count
- 24
- Registration Number
- NCT01062009
- Locations
- 🇺🇸
Childrens' Hospital & Research Center Oakland, Oakland, California, United States
Studies of Immune Responses to Orally Administered Vaccines in Developing Country
- Conditions
- CholeraTyphoid
- Interventions
- First Posted Date
- 2009-11-25
- Last Posted Date
- 2011-07-12
- Target Recruit Count
- 1016
- Registration Number
- NCT01019083
- Locations
- 🇧🇩
Firdausi Qadri, Dhaka, Bangladesh
Prevention Chemotherapy Induced Mucositis by Zinc Sulfate
- Conditions
- MucositisBone Marrow Transplantation
- Interventions
- Drug: Placebo
- First Posted Date
- 2009-11-18
- Last Posted Date
- 2011-07-26
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 60
- Registration Number
- NCT01015183
- Locations
- 🇮🇷
Hematology-Oncology & SCT Research Center, Tehran, Iran, Islamic Republic of
Comparing the Efficacy of Different Zinc Formulations in the Treatment of Diarrhea
- Conditions
- Incidence of Acute DiarrheaIncidence of Abdominal Pain
- Interventions
- First Posted Date
- 2008-05-23
- Last Posted Date
- 2008-05-23
- Lead Sponsor
- Aga Khan University
- Target Recruit Count
- 300
- Registration Number
- NCT00682955
- Locations
- 🇵🇰
National Institute of Child Health, Karachi, Sindh, Pakistan
🇵🇰Civil Hospital, Hyderabad, Sindh, Pakistan
Zinc Sulfate in the Treatment of Rosacea: A Randomized, Controlled Trial
- First Posted Date
- 2006-11-02
- Last Posted Date
- 2011-06-30
- Lead Sponsor
- Essentia Health
- Target Recruit Count
- 65
- Registration Number
- NCT00395226
- Locations
- 🇺🇸
St. Mary's Duluth Clinic Health System, Duluth, Minnesota, United States
Zinc-ORS in Severe and Complicated Acute Diarrhea
- Conditions
- DiarrheaDehydration
- First Posted Date
- 2006-09-01
- Last Posted Date
- 2010-05-13
- Lead Sponsor
- Centre For International Health
- Target Recruit Count
- 352
- Registration Number
- NCT00370968
- Locations
- 🇮🇳
All India Institute of Medical Sciences, New Delhi, India
🇮🇳Deen Dayal Upadhyaya Hospital, New Delhi, India
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.